CKD & Pre-Dialysis Programs
Programs managing chronic kidney disease before dialysis initiation.
Market snapshot
These figures describe Nephrology & Dialysis (4.10.13), the segment that CKD & Pre-Dialysis Programs sits within — not CKD & Pre-Dialysis Programs on its own.
- Market size
- ~$30B
- Growth
- ~3.9%CAGR (2017–22, nominal)
- Companies
- ~8,400
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 621492 (Kidney Dialysis Centers).
Business model & economics
Revenue model
Recurring dialysis-treatment reimbursement (largely Medicare)
Key economics
- Recurring revenue
- High
- EBITDA margin
- Reimbursement-policy-driven
- Capex intensity
- High
thrice-weekly recurring treatment
Characteristics
- Consolidated duopoly (DaVita, Fresenius).
- Chronic, recurring, largely Medicare-funded.
- Shift toward integrated value-based kidney care.
Geographic concentration
Nephrology and dialysis services concentrate across the Southeast — Louisiana, Alabama, Tennessee, and Georgia — tracking the region's elevated diabetes and kidney-disease burden.
U.S. Census Bureau — 2022 County Business Patterns (establishments by state), NAICS 621492. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Dialysis majors
- Value-based kidney-care platforms
- Nephrology MSOs
What’s driving deals
- Value-based kidney-care integration.
- Chronic kidney-disease prevalence.
- Reimbursement-policy dynamics.
Find CKD & Pre-Dialysis Programs acquisition targets
Search Acquisera’s index for companies classified under CKD & Pre-Dialysis Programs (4.10.13.1) and build a targeted deal pipeline.
Search companies